Document is current
Any future updates will be listed below
-
Authors
Mahadevan, Manasvi
Gopukumar, Kumarpillai
Gupta, Ruchi
Morde, Abhijeet
Patni, Paras
Srinivas, Sahitya Sarvamangala
Bhuvanendran, Arun
Phanindra, Abhijith
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 21 July 2025
First Online: 28 August 2025
Declarations
:
: Manasvi Mahadevan, Kumarpillai Gopukumar are the clinical investigators at Bengaluru Neuro Center, Ruchi Gupta is a clinical investigator at Santosh hospital. Sahitya Sarvamangala Srinivas, Arun Bhuvanendran and Abhijith Phanindra are employees of Invitro Research Solutions Private Limited. Abhijeet Morde and Paras Patni are employees of OmniActive Health Technologies.
: All procedures performed in studies involving human participants were in accordance with the Good Clinical Practice guidelines, the ethical principles originated from Helsinki Declaration and in strict compliance with the “New Drugs and Clinical Trial Rules- 2019,” the Ministry of Health and the Government of India, at all stages of the trial for adherence to protocol. The study activities commenced after obtaining an approval from Santhosh Hospital Institutional Ethics Committee, Bengaluru, India, on the 21st February 2024. The EC was duly apprised of the progress and updates of the trial at regular intervals as per prescribed guidelines.
